Surgeon-performed Outpatient Transoral and Transcervical Ultrasound of the Oropharynx (SPOT-US)
Oropharynx Cancer, Tonsil Cancer, Base of the Tongue Tumor
About this trial
This is an interventional diagnostic trial for Oropharynx Cancer
Eligibility Criteria
Inclusion criteria: Initially assessed by a specialist otorhinolaryngologist with clinical suspicion of head and neck cancer and referred to fast-track cancer work-up. Any of the following objective or subjective symptoms: Visible and/or palpable tumors of the oropharynx. Asymmetry of the tonsils or tongue base. Symptoms including dysphagia, throat pain, and/or referred otalgia where an oropharynx tumor is suspected but not clinically visible. Suspected cervical lymph node metastasis with no visible/palpable primary tumor. Lateral neck cysts in patients aged 40+ years. Adult patients aged 18+ years. Understands Danish or English and can give written informed consent. Exclusion criteria: Prior radiotherapy to the oropharynx. Prior oropharynx cancer. MRI of the oropharynx or PET-CT already performed 3 months prior to inclusion.
Sites / Locations
- Rigshospitalet, Department of Otorhinolaryngology, Head & Neck Surgery & AudiologyRecruiting
- Zealand University Hospital - Køge, Department of Otorhinolaryngology, Head and Neck Surgery
- Århus University Hospital, Department of Otorhinolaryngology, Head & Neck Surgery
Arms of the Study
Arm 1
Experimental
Outpatient Oropharynx Ultrasound
Transoral and/or Transcervical ultrasound of the oropharynx